|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shinagawa T, Tanaka T, Nozawa H, Emoto S,
Murono K, Kaneko M, Sasaki K, Otani K, Nishikawa T, Hata K, et al:
Comparison of the guidelines for colorectal cancer in Japan, the
USA and Europe. Ann Gastroenterol Surg. 19:6–12. 2017.
|
|
3
|
Kim SG, Seo HS, Lee HH, Song KY and Park
CH: Comparison of the differences in survival rates between the 7th
and 8th editions of the AJCC TNM staging System for gastric
adenocarcinoma: A single-institution study of 5,507 patients in
Korea. J Gastric Cancer. 17:212–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haq AI, Schneeweiss J, Kalsi V and Arya M:
The Dukes staging system: A cornerstone in the clinical management
of colorectal cancer. Lancet Oncol. 10:11282009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laubert T, Freitag-Wolf S, Linnebacher M,
König A, Vollmar B and Habermann JK; North German Tumorbank of
Colorectal Cancer (ColoNet) consortium: Stage-specific frequency
and prognostic significance of aneuploidy in patients with sporadic
colorectal cancer - a meta-analysis and current overview. Int J
Colorectal Dis. 30:1015–1028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wein A, Siebler J, Goertz R, Wolff K,
Ostermeier N, Busse D, Kremer AE, Koch F, Hagel A, Farnbacher M, et
al: Successful multidisciplinary treatment with secondary
metastatic liver resection after downsizing by palliative
second-line treatment of colorectal cancer: A Curative Option. Case
Rep Oncol. 9:379–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gherman A, Căinap C, Constantin AM, Cetean
S and Căinap SS: Molecular targeted treatment of metastatic
colorectal cancer: The cardiovascular adverse effects of
Bevacizumab and Cetuximab. Clujul Med. 90:377–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohhara Y, Fukuda N, Takeuchi S, Honma R,
Shimizu Y, Kinoshita I and Dosaka-Akita H: Role of targeted therapy
in metastatic colorectal cancer. World J Gastrointest Oncol.
8:642–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gialeli Ch, Kletsas D, Mavroudis D,
Kalofonos HP, Tzanakakis GN and Karamanos NK: Targeting epidermal
growth factor receptor in solid tumors: Critical evaluation of the
biological importance of therapeutic monoclonal antibodies. Curr
Med Chem. 16:3797–3804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ptashkin RN, Pagan C, Yaeger R, Middha S,
Shia J, O’Rourke KP, Berger MF, Wang L, Cimera R, Wang J, et al:
Chromosome 20q amplification defines a subtype of microsatellite
stable, left-sided colon cancers with wild-type RAS/RAF and better
overall survival. Mol Cancer Res. 15:708–713. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lo Nigro C, Ricci V, Vivenza D, Granetto
C, Fabozzi T, Miraglio E and Merlano MC: Prognostic and predictive
biomarkers in metastatic colorectal cancer anti-EGFR therapy. World
J Gastroenterol. 22:6944–6954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao Z, Shi A, Li R, Wang Y, Wang X and
Zhao J: Microarray bioinformatics in cancer - a review. J BUON.
22:838–843. 2017.PubMed/NCBI
|
|
13
|
Sirisena ND, Deen K, Mandawala DEN, Herath
P and Dissanayake VH: The pattern of KRAS mutations in metastatic
colorectal cancer: A retrospective audit from Sri Lanka. BMC Res
Notes. 10:3922017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bamford S, Dawson E, Forbes S, Clements J,
Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR,
et al: The COSMIC (Catalogue of Somatic Mutations in Cancer)
database and website. Br J Cancer. 91:355–358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hiraoka K, Inoue T, Taylor RD, Watanabe T,
Koshikawa N, Yoda H, Shinohara K, Takatori A, Sugimoto H, Maru Y,
et al: Inhibition of KRAS codon 12 mutants using a novel
DNA-alkylating pyrrole-imidazole polyamide conjugate. Nat Commun.
6:67062015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets - update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar
|
|
17
|
Pathan M, Keerthikumar S, Ang CS, Gangoda
L, Quek CY, Williamson NA, Mouradov D, Sieber OM, Simpson RJ, Salim
A, et al: FunRich: An open access standalone functional enrichment
and interaction network analysis tool. Proteomics. 15:2597–2601.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Geer Wallace MA and Pleil JD: Dataset of
breath research manuscripts curated using PubMed search strings
from 1995-2016. Data Brief. 18:1711–1724. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song E, Song W, Ren M, Xing L, Ni W, Li Y,
Gong M, Zhao M, Ma X, Zhang X, et al: Identification of potential
crucial genes associated with carcinogenesis of clear cell renal
cell carcinoma. J Cell Biochem. 119:5163–5174. 2018. View Article : Google Scholar
|
|
21
|
Liang K, Zhou G, Zhang Q, Li J and Zhang
C: Expression of hippo pathway in colorectal cancer. Saudi J
Gastroenterol. 20:188–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mansour RN, Enderami SE, Ardeshirylajimi
A, Fooladsaz K, Fathi M and Ganji SM: Evaluation of hypoxia
inducible factor-1 alpha gene expression in colorectal cancer
stages of Iranian patients. J Cancer Res Ther. 12:1313–1317. 2016.
View Article : Google Scholar
|
|
23
|
Qasim BJ, Al-Wasiti EA and Azzal HS:
Association of global DNA hypomethylation with clinicopathological
variables in colonic tumors of Iraqi patients. Saudi J
Gastroenterol. 22:139–147. 2016.PubMed/NCBI
|
|
24
|
Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y,
Zhang F, Lu Y, Zheng L, Zhang W, Li X, et al: Long non-coding RNA
CASC11 interacts with hnRNP-K and activates the WNT/β-catenin
pathway to promote growth and metastasis in colorectal cancer.
Cancer Lett. 376:62–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhai F, Song N, Ma J, Gong W, Tian H, Li
X, Jiang C and Wang H: FGF18 inhibits MC3T3 E1 cell osteogenic
differentiation via the ERK signaling pathway. Mol Med Rep.
16:4127–4132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Z, Wang Y, Zhang J, Zhong J and Yang
R: COL1A1 promotes metastasis in colorectal cancer by regulating
the WNT/PCP pathway. Mol Med Rep. 17:5037–5042. 2018.PubMed/NCBI
|
|
27
|
Chang Z, Shi G, Jin J, Guo H, Guo X, Luo
F, Song Y and Jia X: Dual PI3K/mTOR inhibitor NVP-BEZ235-induced
apoptosis of hepatocellular carcinoma cell lines is enhanced by
inhibitors of autophagy. Int J Mol Med. 31:1449–1456. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li S, Hu T, Yuan T, Cheng D and Yang Q:
Nucleoside diphosphate kinase B promotes osteosarcoma proliferation
through c-Myc. Cancer Biol Ther. 19:565–572. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang SD, Yuan Y, Zhuang CW, Li BL, Gong
DJ, Wang SG, Zeng ZY and Cheng HZ: MicroRNA-98 and microRNA-214
post-transcriptionally regulate enhancer of zeste homolog 2 and
inhibit migration and invasion in human esophageal squamous cell
carcinoma. Mol Cancer. 11:512012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Biggs MB and Papin JA: Managing
uncertainty in metabolic network structure and improving
predictions using EnsembleFBA. PLOS Comput Biol. 13:pp.
e10054132017, View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mo CH, Gao L, Zhu XF, Wei KL, Zeng JJ,
Chen G and Feng ZB: The clinicopathological significance of UBE2C
in breast cancer: A study based on immunohistochemistry, microarray
and RNA-sequencing data. Cancer Cell Int. 17:832017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar
|
|
33
|
Bertotti A, Papp E, Jones S, Adleff V,
Anagnostou V, Lupo B, Sausen M, Phallen J, Hruban CA, Tokheim C, et
al: The genomic landscape of response to EGFR blockade in
colorectal cancer. Nature. 526:263–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yun J, Mullarky E, Lu C, Bosch KN,
Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, et
al: Vitamin C selectively kills KRAS and BRAF mutant colorectal
cancer cells by targeting GAPDH. Science. 350:1391–1396. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rask-Andersen M, Almén MS and Schiöth HB:
Trends in the exploitation of novel drug targets. Nat Rev Drug
Discov. 10:579–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Elkin M, Miao HQ, Nagler A, Aingorn E,
Reich R, Hemo I, Dou HL, Pines M and Vlodavsky I: Halofuginone: A
potent inhibitor of critical steps in angiogenesis progression.
FASEB J. 14:2477–2485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Byers PH and Pyott SM: Recessively
inherited forms of osteogenesis imperfecta. Annu Rev Genet.
46:475–497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J, Ding Y and Li A: Identification of
COL1A1 and COL1A2 as candidate prognostic factors in gastric
cancer. World J Surg Oncol. 14:2972016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song Y, Kim SH, Kim KM, Choi EK, Kim J and
Seo HR: Activated hepatic stellate cells play pivotal roles in
hepatocellular carcinoma cell chemoresistance and migration in
multicellular tumor spheroids. Sci Rep. 6:367502016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang H, Liu B, Xu XF, Jiang TT, Zhang XQ,
Shi YL, Chen Y, Liu F, Gu J, Zhu LJ, et al: Pathophysiology of
chronic pancreatitis induced by dibutyltin dichloride joint ethanol
in mice. World J Gastroenterol. 22:2960–2970. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Boguslawska J, Kedzierska H, Poplawski P,
Rybicka B, Tanski Z and Piekielko-Witkowska A: Expression of genes
involved in cellular adhesion and extracellular matrix remodeling
correlates with poor survival of patients with renal cancer. J
Urol. 195:1892–1902. 2016. View Article : Google Scholar
|
|
42
|
Brooks M, Mo Q, Krasnow R, Ho PL, Lee YC,
Xiao J, Kurtova A, Lerner S, Godoy G, Jian W, et al: Positive
association of collagen type I with non-muscle invasive bladder
cancer progression. Oncotarget. 7:82609–82619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Poplawski P, Rybicka B, Boguslawska J,
Rodzik K, Visser TJ, Nauman A and Piekielko-Witkowska A: Induction
of type 1 iodothyronine deiodinase expression inhibits
proliferation and migration of renal cancer cells. Mol Cell
Endocrinol. 442:58–67. 2017. View Article : Google Scholar
|
|
44
|
Suzuki K, Kokuryo T, Senga T, Yokoyama Y,
Nagino M and Hamaguchi M: Novel combination treatment for
colorectal cancer using Nek2 siRNA and cisplatin. Cancer Sci.
101:1163–1169. 2010. View Article : Google Scholar : PubMed/NCBI
|
